Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

CSL Behring Scoops U.S. Biotech Calimmune

CSL Ltd. bought Tucson, Ariz.-based Calimmune for $91 million upfront and up to $325 million in performance-based milestones.

Read More »

A First: Novartis AG Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too

An anti-inflammatory drug developed for cardiac patients has an exciting, yet unintended side effect – possible prevention of lung cancer.

Read More »

Bayer, J&J in frame for bigger anti-clotting market opportunity

Bayer and Johnson & Johnson’s blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 percent, raising the prospects of billions more in sales.

Read More »

Surgeons in France reattach woman’s arms after train accident

Surgeons re-attached a woman’s arms after they were severed by a train, a rare operation and a first in France in that both limbs were worked on at the same time.

Read More »

FDA clears Novo Nordisk’s diabetes drug to reduce cardiovascular risk

The FDA approved an expanded use of Novo Nordisk’s diabetes drug Victoza to reduce the risk of cardiovascular events such as heart attack and stroke.

Read More »

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s role in ensuring Americans have access to clear and consistent calorie and nutrition information

“As a doctor, father and the head of the U.S. Food & Drug Administration, I believe that everyone is entitled to the information they need to make informed decisions about the food they eat. We serve as the nation’s expert on food labeling, which is why Congress entrusted us with the responsibility of crafting predictable, uniform federal standards that will benefit the health of families across America by ensuring access to essential calorie and nutrition information on food and menu labels.”

Read More »

Troubled Dimension Therapeutics Sold in All-Stock Deal

Shares of beleaguered Dimension Therapeutics Inc. soared more than 160 percent in premarket trading after gene therapy company Regenxbio Inc. announced its acquisition via an all-stock deal.

Read More »

The FDA Calls Kyowa Hakko Kirin’s Lymphoma Drug a Breakthrough

The U.S. Food and Drug Administration granted its Breakthrough Therapy Designation to a drug that has been available to lymphoma patients in Japan for several years.

Read More »

Pfizer Picks New HQ in Big Apple

Pfizer reportedly chose a site for the company’s new headquarters, the as-yet constructed Manhattan skyscraper The Spiral.

Read More »

Biosimilar version of Humira approved in Europe

A biosimilar version of AbbVie Inc.’s blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc. and Samsung Biologics, was approved by EU regulators.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom